Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Jan 01, 2013
Method for the production of fluoromethyl esters of androstane-17_-carboxylic acids
Read more
Scientific Article
/ Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Read more
Scientific Article
/ Jan 01, 2012
Preparation of electrophilic sulfur reagents for monohalomethylation of steroids
Read more
Scientific Article